Here is my Scopus list of publications.
On PubMed, you'll only find my publications.
Chapman, E., & Coyle, S. (n.d.).
Predicting the last days of life will change clinical practice.
BMJ Supportive and Palliative Care. doi:10.1136/bmjspcare-2020-002187
PubMed article | BMJ Supportive and Palliative Care | Liverpool Repository | Download a PDF (unformatted, but accepted)|
Chapman, E. A., Lyon, M., Simpson, D., Mason, D., Beynon, R. J., Moots, R. J., & Wright, H. L.
Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.
FRONTIERS IN IMMUNOLOGY, 10:423. (11 March 2019) DOI: 10.3389/fimmu.2019.00423
PubMed article | PubMed Central article | Frontiers in Immunology online | Download a PDF.
Glennon-Alty L*, Hackett AP*, Chapman EA*, Wright HL.
Neutrophils and redox stress in the pathogenesis of autoimmune disease.
Free Radic Biol Med. 2018 Mar 29. pii: S0891-5849(18)30159-X. https://doi.org/10.1016/j.freeradbiomed.2018.03.049
PubMed article | Free Radic Biol Med. online | Download a PDF.
*Joint first author. Contributed equally. I authored the NETs, SLE and APS sections. I also helped offer significant and minor edits to the final draft.
Elinor Chapman, Melanie Oates, Ishaque Mohammad, Barry Davies, Paul Stockman, Andrew Pettitt, Jianguo Zhuang. (2017).
Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia Oncotarget, Accepted: 26/10/2017 | https://doi.org/10.18632/oncotarget.22292
PubMed article | PubMed Central article | Oncotarget online | Download a PDF.
My PhD Thesis
Chapman, E. A. (2016). The role and regulation of AKT in CD40-mediated survival and proliferation of CLL cells.(University of Liverpool).
Abstracts
Zhuang, J., Chapman, E., Stockman, P., Davies, B., & Pettitt, A. (2015). Distinct requirement of AKT for CD40-induced cell growth and division in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA, 56, 16-18.
Abstracts at XVI International Workshop on Chronic Lymphocytic Leukemia 2015 6–9 September 2015 Sydney, Australia
Retrieved from http://gateway.webofknowledge.com/
http://www.tandfonline.com/toc/ilal20/56/sup1 |Download PDF of abstracts (page 17/167).
Poster Abstracts
International Workshop on CLL (iwCLL) Cologne, German.
9-11 September 2013: Poster 3.3 “The novel Akt inhibitor AZD5363 enhances cytotoxicity of bendamustine in CD40-stimulated primary chronic lymphocytic leukaemia cells and prevents leukemic cells from proliferating in response to CD40/IL-4 stimulation”.
Download a PDF of all the abstracts at iwCLL 2013 (page 75/267).
Journal article
Holmes, K., Williams, M. C., Chapman, E. A., & Cross, M. J. (2010). Detection of siRNA induced mRNA silencing by RT-
qPCR: considerations for experimental design. BMC Research Notes, 3, 53.
PubMed article | PubMed Central article | BMC Research Notes | Download a PDF.
Journal article
Holmes, K., Chapman, E., See, V., & Cross, M. J. (2010). VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca2+/Calcineurin and Protein Kinase C-δ. PLoS ONE, 5(7), e11435. doi:10.1371/journal.pone.0011435
PubMed article | PubMed Central Article | PLoS One website. | Download a PDF.
Abstracts
15-17th July 2009: The Biochemical Society Molecular and cellular mechanisms of angiogenesis, Chester. P034 The role of RCAN1 in VEGFR-2-mediated angiogenesis Katherine Holmes, Elinor Chapman, Michael Cross Dept of Pharmacology and Therapeutics, University of Liverpool, L79 3GE http://www.biochemistry.org/Portals/0/Conferences/abstracts/SA102/SA102P034.pdf